You have 9 free searches left this month | to do more

lenalidomide

Lenalidomide is a drug used to treat Multiple Myeloma, Chronic Lymphocytic Leukemia, Lymphoma, and other conditions. Lenalidomide is being actively studied in 273 studies and prior, has been studied in 248.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterMayo ClinicIrene Ghobrial, MD
National Cancer Institute (NCI)Washington University School of MedicineJacob Laubach
CelgeneM D Anderson Cancer CenterZhao Weili
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-06-11
Jun 11, 2021
A
Maintenance Lenalidomide in Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
S
Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2021-08-20
Aug 20, 2021
U
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
W
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
Active, not recruiting
Has Results
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
2021-05-13
May 13, 2021
M
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
Active, not recruiting
  • MULTIPLE MYELOMA (MM)
  • Rionero in Vulture, Italy
    IRCCS--CROB --CROB di Rionero in di Rionero in Vulture
2021-04-28
Apr 28, 2021
H
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma
Recruiting
  • Central Nervous System Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib
  • +2 more
  • Zhengzhou, Henan, China
    Henan cancer hospital
2021-06-16
Jun 16, 2021
M
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185) - 2020
Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +2 more
  • (no location specified)
2021-06-29
Jun 29, 2021
M
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2021-07-13
Jul 13, 2021
U
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-02-04
Feb 4, 2021
H
Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma - 2020
Completed
Has Results
  • Multiple Myeloma
  • Lenalidomide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-10-08
Oct 8, 2021
N
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas - 2019
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-13
Oct 13, 2021
M
A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Not yet recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
    University of Miami
2021-09-09
Sep 9, 2021
U
Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
Active, not recruiting
  • Richter's Syndrome
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-04-08
Apr 8, 2021
B
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2021-06-27
Jun 27, 2021
T
A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone - 2021
Completed
  • Relapsed and/or Refractory Multiple Myeloma
  • Tokyo, Japan
    Takeda Selected Site
2021-06-03
Jun 3, 2021
H
Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-01-30
Jan 30, 2021
W
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2021-09-02
Sep 2, 2021
S
Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma
Recruiting
  • Primary Central Nervous System Lymphoma
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
2021-06-20
Jun 20, 2021
H
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-08-15
Aug 15, 2021
M
Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
Recruiting
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Laboratory Biomarker Analysis
  • Lenalidomide
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-16
Jun 16, 2021
W
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL - 2020
Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
2021-03-23
Mar 23, 2021
B
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)
Recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62 Injection
  • Lenalidomide
  • Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
2021-06-15
Jun 15, 2021
F
Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Active, not recruiting
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
2021-04-13
Apr 13, 2021
D
A Study of Lenalidomide for Adult Histiocyte Disorders
Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Lenalidomide
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2020-11-23
Nov 23, 2020